4QS-21839-04568
2 vaccinations
1 coded response
14 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 773 / TX
- Registered
- 2020-12-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-28
Dose 1 — Moderna
-
2020-12-29
Registered in v-safe
-
2020-12-29
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-13
- 2021-01-19
-
2021-01-25
Dose 2 — Moderna
- 2021-02-02
- 2021-02-08
-
2021-02-22
Survey response — day 28, dose 2MedDRA: Disturbance in attention, Feeling abnormal, Memory impairment — Feeling: GoodFree text: Foggy memory. Poor concentrationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-26
- 2022-01-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Moderna | |
| 2 | 2021-01-25 | Moderna |
Free text
Release 4 — day 28, dose 2
Symptoms: Foggy memory. Poor concentration
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Disturbance in attention | ✓ | ✓ | ✓ |
| SD | Feeling abnormal | ○ | ✓ | ○ |
| SD | Memory impairment | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release